Asterion Cannabis Inc.

  • Land: .

Nachricht vom 23.05.2019 | 21:19

Asterion to Hold 2019 Annual General Meeting and Corporate Presentations

DGAP-News: Asterion Cannabis Inc. / Key word(s): Miscellaneous

23.05.2019 / 21:19
The issuer is solely responsible for the content of this announcement.


Vancouver, British Columbia--(Newsfile Corp. - May 23, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company") announces that the Company's 2019 Annual General Meeting of Shareholders will be held at the Fairmont Vancouver Hotel in the Saturna Room, 900 West Georgia Street, Vancouver, BC, Canada on Thursday, June 20, 2019 at 12:00 p.m.

Asterion is also pleased to announce that it will be hosting two corporate events involving presentations from Asterion's senior management, details of which are set out below. Presenters at the events are expected to include Mr. Stephen Van Deventer, Chairman and CEO, Mr. Paget Hargreaves, President and Director, Mr. Hamish Sutherland, Chief Operating Officer and Mr. Stewart McGlashan, Director of Project Development.

Due to limited space, please pre-register for the events to secure your spot.

Toronto Corporate Presentation Event Details
Date: Tuesday, June 18th, 2019
Time: 1:00 pm - 4:00 pm
Presentation: 1:30 pm - 2:30 pm
Location: Fairmont Royal York
Tudor Room 7 and 8
100 Front St W, Toronto, Ontario

MC: Stephen Van Deventer

Toronto - Confirm your attendance, register by clicking here: Toronto Eventbrite Link

Vancouver Corporate Presentation Event Details
Date: Thursday, June 20th, 2019
Time 1:00 pm - 4:00 pm
Presentation: 1:30 - 2:30
Location: Fairmont Vancouver Hotel
Saturna Room
900 West Georgia Street, Vancouver, British Columbia
MC: Stephen Van Deventer

Vancouver - Confirm your attendance, register by clicking here: Vancouver Eventbrite Link

About Asterion

Asterion is a Canadian medicinal cannabis company with operations in Australia, specializing in medical cannabis and is focused on becoming an industry leader in next-generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality of genetically uniform cannabis strains, at an affordable price.

The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.

On Behalf of the Board of Directors

"Stephen Van Deventer"
Chairman & Chief Executive Officer

For further information, please contact:

Deanna Kress
+1-778-999-6063
info@asterioncannabis.com

Forward-Looking Statements:

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. Other than statements of historical fact, all statements included in this news release, including, without limitation, statements regarding the Company's anticipated business plans and prospects of success in executing its plans, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Various risks and uncertainties could cause actual results to differ materially from Asterion's expectations. Other factors such as general economic, market or business conditions, future prices of cannabis, changes in the financial markets and in the demand and market price for cannabis, or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45012

Click on, or paste the following link into your web browser,to view the associated documents http://www.newsfilecorp.com/release/45012


23.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

VST BUILDING TECHNOLOGIES AG: 7,00%-Anleihe 2019/2024 kann ab heute gezeichnet werden.

Emissionsvolumen der 5-jährigen Anleihe bis zu 15 Mio. Euro, Zeichnungsfrist vom 11.06.-25.06.2019


- WKN/ ISIN: A2R1SR / DE000A2R1SR7
- Stückelung: 1.000 Euro
- Kupon: 7,00 Prozent p.a. bei halbjährlicher Zinszahlung
- Zeichnungsfrist über Zeichnungsfunktionalität Börse Frankfurt voraussichtlich: 11 Juni 2019 bis 25 Juni 2019 (14:00 Uhr MESZ)
- Laufzeit: 28. Juni 2019 bis einschließlich 27. Juni 2024
- Rückzahlung: 28. Juni 2024
- Zinstermin: Halbjährlich

Interview im Fokus

„Schnelleres Wachstum mit Wasserstoff“

Mit dem Einstieg in die Wasserstoff-Technologie erschließt sich SFC Energy ein besonders dynamisches Segment. „Mittelfristig ist das Marktvolumen für Wasserstoff-Brennstoffzellen noch größer als im Direkt-Methanol-Bereich. Zivile Massenanwendungen könnten sich dabei zu einem echten Wachstumsbooster entwickeln“, ist CEO Dr. Peter Podesser überzeugt. Im Financial.de-Interview spricht der SFC-Vorstandschef u. a. über die aktuelle Euphorie für Brennstoffzellen-Aktien, die geplante Kapitalmaßnahme und das mittelfristige Umsatzziel von 100 Mio. Euro.

GBC-Fokusbox

Studie GBC Best of m:access I.2019: Weiter im Aufwind und mit starker Outperformance

Das Qualitätssegment m:access hat sich in den letzten Jahren fulminant entwickelt und ist auch 2018 weiter gewachsen. Zuletzt umfasste der m:access einen Rekordwert von 60 Unternehmen unterschiedlichster Branchen mit einer Gesamtmarktkapitalisierung von rund EUR 12 Mrd. Der von GBC berechnete m:access Index hat im Betrachtungszeitraum eine starke Outperformance gezeigt. Auch für die neue Top 15 Best-Of-Auswahl sind die Analysten wieder sehr positiv gestimmt. Die Studie steht kostenlos zum Download zur Verfügung.

News im Fokus

Infineon Technologies AG: Infineon setzt den Platzierungspreis für die neuen Aktien fest

17. Juni 2019, 23:59

Aktueller Webcast

Stealth BioTherapeutics

The BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

25. Juni 2019

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

19. Juni 2019